Contact this trialFirst, we need to learn more about you.
Phosphodiesterase Inhibitor
Inhaled nebulized milrinone for Heart Failure
Recruiting2 awardsPhase 1
Nashville, Tennessee
This trial is testing a new way to give the heart failure medication milrinone using an inhaler instead of through an IV. The goal is to see if this new way lowers the levels of plasma milrinone, which may lessen the chance of medication side effects, while still preserving the beneficial effects of milrinone.
Fill-in a few details and create your profileHaving a profile will help us send you recommended trials and speed up your application in the future.
We will keep your details privateWe won’t share unless you give us permission. By completing this form you agree to our privacy policy
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.